{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:39:34Z","timestamp":1788871174067,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["41206130"],"award-info":[{"award-number":["41206130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31470236"],"award-info":[{"award-number":["31470236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"high school technology innovation project of Guangdong province","award":["cxzd1127"],"award-info":[{"award-number":["cxzd1127"]}]},{"name":"We thank Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University for their test of cell apoptosis"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ejmech.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T13:10:37Z","timestamp":1428412237000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents"],"prefix":"10.1016","volume":"96","author":[{"given":"Junjun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.04.005_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4","article-title":"The association of benign prostatic hyperplasia and cancer of the prostate","volume":"70","author":"Bostwick","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2015.04.005_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0090-4295(99)80016-8","article-title":"Citrate as an in\u00a0vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy","volume":"45","author":"Kurhanewicz","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.ejmech.2015.04.005_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1940-6207.CAPR-10-0189","article-title":"Naftopidil, a selective \u03b11-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma","volume":"4","author":"Hori","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ejmech.2015.04.005_bib4","first-page":"243","article-title":"Therapeutic strategies for benign prostatic hypertrophy","volume":"1","author":"Hieble","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2015.04.005_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1442-2042.2007.01956.x","article-title":"\u03b11-Adrenoceptor subtypes and lower urinary tract symptoms","volume":"15","author":"Schwinn","year":"2008","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00169183","article-title":"Classification of \u03b11-adrenoceptor subtypes","volume":"352","author":"Michel","year":"1995","journal-title":"N-S Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/bjp.2008.245","article-title":"The \u03b11A-adrenoceptor gene is required for the \u03b11L-adrenoceptor-mediated response in isolated preparations of the mouse prostate","volume":"155","author":"Gray","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib8","first-page":"1513","article-title":"Modulation of bladder \u03b11-adrenergic receptor subtype expression by bladder outlet obstruction","volume":"167","author":"Hampel","year":"2002","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib9","first-page":"1029","article-title":"\u03b11-Adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia","volume":"171","author":"Roehrborn","year":"2004","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib10","first-page":"4550","article-title":"Suppression of human prostate cancer cell growth by \u03b11-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis","volume":"60","author":"Kyprianou","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2015.04.005_bib11","first-page":"597","article-title":"Quinazoline-derived \u03b11-adrenoceptor antagonists induce prostate cancer cell apoptosis via an \u03b11-adrenoceptor-independent action","volume":"62","author":"Benning","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2015.04.005_bib12","first-page":"1520","article-title":"Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance","volume":"169","author":"Kyprianou","year":"2003","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/sj.bjc.6600961","article-title":"Quinazoline-based \u03b11-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-\u03b2 signalling and I\u03baB\u03b1 induction","volume":"88","author":"Partin","year":"2003","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.ejmech.2015.04.005_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1254\/jjp.79.447","article-title":"Naftopidil, a novel \u03b11-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human \u03b1 1-adrenoceptors","volume":"79","author":"Takei","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.23095","article-title":"Naftopidil, a selective \u03b11 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest","volume":"122","author":"Kanda","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2015.04.005_bib16","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1016\/j.bmcl.2010.07.101","article-title":"Search for influence of spatial properties on affinity at \u03b11-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin","volume":"20","author":"Handzlik","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.04.005_bib17","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1016\/j.ejmech.2011.04.032","article-title":"Discovery of LASSBio-772, a 1, 3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A\/D-Adrenergic receptor blocking properties","volume":"46","author":"Romeiro","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0022-3565(24)39060-3","article-title":"An investigation of the uroselective properties of four novel \u03b11a-adrenergic receptor subtype-selective antagonists","volume":"294","author":"Pulito","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2015.04.005_bib19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4161\/cc.4.9.1993","article-title":"Molecular targets and anticancer potential of indole-3-carbinol and its derivatives","volume":"4","author":"Aggarwal","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2015.04.005_bib20","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/sj.onc.1204365","article-title":"Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells","volume":"20","author":"Chinni","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2015.04.005_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional \u03b11-adrenoceptor","volume":"67","author":"Docherty","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2015.04.005_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/jm049153d","article-title":"Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds","volume":"48","author":"Antonello","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib23","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1021\/jm0580398","volume":"48","author":"Quaglia","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib24","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1016\/j.ejmech.2010.09.042","article-title":"Synthesis and \u03b11-adrenoceptor antagonist activity of tamsulosin analogues","volume":"45","author":"Sagratini","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1124\/jpet.300.2.478","article-title":"Preclinical pharmacology of fiduxosin, a novel \u03b11-adrenoceptor antagonist with uroselective properties","volume":"300","author":"Hancock","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2015.04.005_bib26","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1021\/jm8016046","article-title":"Doxazosin-related \u03b11-adrenoceptor antagonists with prostate antitumor activity","volume":"52","author":"Giardin\u00e0","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0092-8674(95)90407-7","article-title":"Heterotrimeric C proteins: organizers of transmembrane signals","volume":"80","author":"Neer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2015.04.005_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0026-895X(25)10156-9","article-title":"The alpha1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha1c subtype","volume":"45","author":"Forray","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0026-895X(25)09946-8","article-title":"\u03b11-adrenergic stimulation and \u03b22-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells","volume":"37","author":"Nakaki","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1097-0045(19990215)38:3<216::AID-PROS6>3.0.CO;2-0","article-title":"Influence of the alpha1-adrenergic antagonist, doxazosin, on noradrenaline-induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells","volume":"38","author":"Smith","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2015.04.005_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tox.2008.10.025","article-title":"Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis","volume":"256","author":"Liou","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2015.04.005_bib32","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/jm9905918","article-title":"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective \u03b11a-adrenergic receptor antagonists","volume":"43","author":"Kuo","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib33","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.100.23.2336","article-title":"Subtype specific regulation of human vascular \u03b11-adrenergic receptors by vessel bed and age","volume":"100","author":"Rudner","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2015.04.005_bib34","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/iju.12156","article-title":"Reduction of prostate cancer incidence by naftopidil, an \u03b11-adrenoceptor antagonist and transforming growth factor-\u03b2 signaling inhibitor","volume":"20","author":"Daisuke","year":"2013","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejmech.2015.04.005_bib35","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1210\/en.2004-0728","article-title":"Differential regulation of the cell cycle by \u03b11-adrenergic receptor subtypes","volume":"145","author":"Gonzalez-Cabrera","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2015.04.005_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/0929867023371030","article-title":"Arylpiperazine derivatives acting at 5-HT1A receptors","volume":"9","author":"L\u00f3pez-Rodr\u00edguez","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib37","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2174\/0929867054367220","article-title":"Derivatives as 5-HT1A receptor ligands\u2013past and present","volume":"12","author":"Caliendo","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.005_bib38","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/j.bmc.2009.06.019","article-title":"\u2018Click\u2019 D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity","volume":"17","author":"Zhang","year":"2009","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415002548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415002548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T19:54:34Z","timestamp":1747857274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415002548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":38,"alternative-id":["S0223523415002548"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.005","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}